Literature DB >> 11896456

The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3.

Hajnalka Kiss1, Ying Yang, Csaba Kiss, Kenth Andersson, George Klein, Stephan Imreh, Jan P Dumanski.   

Abstract

Occurrence of chromosome 3p deletions in a large number of human tumours suggests the existence of uncharted tumour suppressor gene(s). We previously applied a functional assay, named the Elimination test (Et), for the identification of regions containing tumour growth antagonising genes. This resulted in the definition of chromosome 3 common eliminated region 1 (C3CER1) on 3p21.3, which is regularly eliminated from SCID-derived tumours. Systematic genomic sequencing of 11 PAC clones, combined with comparisons of genomic sequence against EST databases and PCR-based cloning of cDNA sequences allowed us to assemble a comprehensive transcriptional map of 1.4 Mb that includes 19 active genes and three processed pseudogenes. We report four novel genes: FYVE and coiled-coil domain containing 1 (FYCO1), transmembrane protein 7 (TMEM7), leucine-rich repeat-containing 2 (LRRC2) and leucine zipper protein 3 (LUZP3). A striking feature of C3CER1 is a presence of a cluster of eight chemokine receptor genes. Based on a new analysis of the microcell hybrid-derived panel of SCID tumours we also redefined the centromeric border of the C3CER1. It is now located within LRRC2 gene, which is a relative of RSP-1 (Ras Suppressor Protein 1). The detailed knowledge of gene content in C3CER1 is a prerequisite for functional analysis of these genes and understanding of their possible role in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896456     DOI: 10.1038/sj.ejhg.5200758

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

1.  Mutations in FYCO1 cause autosomal-recessive congenital cataracts.

Authors:  Jianjun Chen; Zhiwei Ma; Xiaodong Jiao; Robert Fariss; Wanda Lee Kantorow; Marc Kantorow; Eran Pras; Moshe Frydman; Elon Pras; Sheikh Riazuddin; S Amer Riazuddin; J Fielding Hejtmancik
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

2.  VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells.

Authors:  Xiangcang Ye; Fan Fan; Rajat Bhattacharya; Seth Bellister; Delphine R Boulbes; Rui Wang; Ling Xia; Cristina Ivan; Xiaofeng Zheng; George A Calin; Jing Wang; Xiongbin Lu; Lee M Ellis
Journal:  Mol Cancer Res       Date:  2015-06-03       Impact factor: 5.852

3.  Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3.

Authors:  Maria Kost-Alimova; Hajnalka Kiss; Ludmila Fedorova; Ying Yang; Jan P Dumanski; George Klein; Stefan Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

4.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

5.  The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma.

Authors:  Xiaoling Zhou; Nicholas C Popescu; George Klein; Stephan Imreh
Journal:  Cancer Genet Cytogenet       Date:  2007-08

6.  LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription.

Authors:  Tyson V Sharp; Fernando Munoz; Dimitra Bourboulia; Nadege Presneau; Eva Darai; Hsei-Wei Wang; Mark Cannon; David N Butcher; Andrew G Nicholson; George Klein; Stephan Imreh; Chris Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-12       Impact factor: 11.205

7.  Genome-wide association study for femoral neck bone geometry.

Authors:  Lan-Juan Zhao; Xiao-Gang Liu; Yao-Zhong Liu; Yong-Jun Liu; Christopher J Papasian; Bao-Yong Sha; Feng Pan; Yan-Fang Guo; Liang Wang; Han Yan; Dong-Hai Xiong; Zi-Hui Tang; Tie-Lin Yang; Xiang-Ding Chen; Yan Guo; Jian Li; Hui Shen; Feng Zhang; Shu-Feng Lei; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

8.  A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.

Authors:  Anna Vert; Jessica Castro; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Oncotarget       Date:  2016-04-05

9.  Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.

Authors:  Tomasz Wrzesiński; Malgorzata Szelag; Wojciech A Cieślikowski; Agnieszka Ida; Rachel Giles; Elżbieta Zodro; Joanna Szumska; Joanna Poźniak; Zbigniew Kwias; Hans A R Bluyssen; Joanna Wesoly
Journal:  BMC Cancer       Date:  2015-07-14       Impact factor: 4.430

10.  FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport.

Authors:  Serhiy Pankiv; Endalkachew A Alemu; Andreas Brech; Jack-Ansgar Bruun; Trond Lamark; Aud Overvatn; Geir Bjørkøy; Terje Johansen
Journal:  J Cell Biol       Date:  2010-01-25       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.